IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas
Adriana Olar(Medical University of South Carolina), Kenneth Aldape(National Institutes of Health)
Cited by 350
Related Papers
Challenges to curing primary brain tumours
|Nature Reviews Clinical Oncology|2019|965
The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma
|Genes & Development|2011|375
CIC protein instability contributes to tumorigenesis in glioblastoma
|Nature Communications|2019|90
Selective repression of YKL‐40 by NF‐κB in glioma cell lines involves recruitment of histone deacetylase‐1 and ‐2
|FEBS Letters|2008|46
A gene expression signature predicts recurrence-free survival in meningioma
|Oncotarget|2018|31